Financials

  • Market Capitalization 1.91 B
  • Employee 161
  • Founded 2019
  • CEO N/A
  • Website www.monterosatx.com
  • Headquarter Delaware, United States
  • FIGI BBG00X2VGZQ3
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-33.72
市销率
10.53

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2016
URGN
UroGen Pharma Ltd. - Ordinary Shares
39.80 USD+0.73%+2.98%+34.69%+109.47%1.94 B USD
2028
TYRA
Tyra Biosciences, Inc. - Common Stock
32.63 USD-0.12%+3.06%+20.01%+127.55%1.94 B USD
2051
NTLA
Intellia Therapeutics, Inc. - Common Stock
13.32 USD+2.30%-22.20%+4.23%-2.92%1.86 B USD
2054
BCAX
Bicara Therapeutics Inc. - Common Stock
28.35 USD+0.71%-6.96%+29.27%+96.33%1.86 B USD

新闻